Schedule 13G ownership disclosure
Ligand Pharmaceuticals Inc
Security class unavailable · CUSIP: 53220K504
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,165,039
- Percent of class
- 5.8200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-040828
- Form type
- SC 13G
- Filer
- BLAIR WILLIAM & CO/IL
- CIK
- CIK 902367
- Filed
- Jul 02, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership